Revenue Growth Broad-Based Across Categories“We were pleased to deliver strong organic growth that not only exceeded the high end of our expectations, but also represents the strongest quarterly organic growth the company has delivered in three years,” Aronson said. The company now expects 2026 GAAP revenue growth of 7.6% to 8.4%, or constant-currency growth of 6.9% to 7.6%. It raised expected organic constant-currency growth to 6.9% to 7.5%, from 6% to 7% previously. About Merit Medical Systems (NASDAQ:MMSI)Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.